Location: Burlington, VT
CIK: 0001618205 · Show all filings
Period: Q3 2023 (← Previous) (Next →)
Filing Date: Jun 30, 2025
Total Value: $117M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| BMY | BRISTOL-MYERS SQUIBB CO | 716,297 | $41.57M | 35.4% | $58.04 * | $44.70 | +21.6% | COM | 110122108 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 77,240 | $8.69M | 7.4% | $112.50 * | $72.40 | +45.4% | COM | 64125C109 |
| — | BIODESIX INC | 5,193,336 | $8.527M | 7.3% | $1.64 | $5.98 | — | COM | 09075X108 |
| PRTA | PROTHENA CORP PLC | 169,574 | $8.182M | 7.0% | $48.25 * | $41.45 | +43.3% | SHS | G72800108 |
| ACAD | ACADIA PHARMACEUTICALS INC | 240,400 | $5.01M | 4.3% | $20.84 * | $35.16 | -22.7% | COM | 004225108 |
| — | QUIDELORTHO CORP | 65,203 | $4.762M | 4.1% | $73.04 | $69.01 | — | COM | 74838J101 |
| OVV | OVINTIV INC | 84,200 | $4.005M | 3.4% | $47.57 * | $33.44 | +35.4% | COM | 69047Q102 |
| — | IMMUNOGEN INC | 190,000 | $3.015M | 2.6% | $15.87 | $6.13 | — | COM | 45253H101 |
| UTHR | UNITED THERAPEUTICS CORP | 11,000 | $2.485M | 2.1% | $225.87 | $93.09 | +147.4% | COM | 91307C102 |
| ELUT | ELUTIA INC | 1,655,184 | $2.367M | 2.0% | $1.43 * | $5.84 | -70.0% | COM | 05479K106 |
| HROW | HARROW HEALTH INC | 150,000 | $2.155M | 1.8% | $14.37 * | $6.05 | +189.2% | COM | 415858109 |
| PHR | PHREESIA INC | 82,700 | $1.545M | 1.3% | $18.68 * | $23.06 | +16.7% | COM | 71944F106 |
| ALKS | ALKERMES PLC | 50,000 | $1.401M | 1.2% | $28.01 * | $21.00 | +39.6% | SHS | G01767105 |
| — | BLUEBIRD BIO INC | 455,200 | $1.384M | 1.2% | $3.04 | $11.94 | — | COM | 09609G100 |
| CORT | CORCEPT THERAPEUTICS INC | 50,000 | $1.362M | 1.2% | $27.25 * | $6.85 | +322.3% | COM | 218352102 |
| MASI | MASIMO CORP | 15,280 | $1.34M | 1.1% | $87.68 * | $81.54 | +42.7% | COM | 574795100 |
| FHTX | FOGHORN THERAPEUTICS INC | 264,843 | $1.324M | 1.1% | $5.00 * | $19.16 | -59.8% | COM | 344174107 |
| — | ACCELERATE DIAGNOSTICS INC | 225,239 | $1.295M | 1.1% | $5.75 | $19.28 | — | COM | 00430H102 |
| — | INHIBRX INC | 70,448 | $1.293M | 1.1% | $18.35 | $31.33 | — | COM | 45720L107 |
| — | EQUITRANS MIDSTREAM CORPORATIO | 133,050 | $1.247M | 1.1% | $9.37 | $8.31 | — | COM | 294600101 |
| ATEC | ALPHATEC HOLDINGS INC | 80,000 | $1.038M | 0.9% | $12.97 * | $9.84 | +59.2% | COM | 02081G201 |
| VTYX | VENTYX BIOSCIENCES INC | 26,400 | $917K | 0.8% | $34.73 | $22.39 | +54.4% | COM | 92332V107 |
| — | PIONEER NATURAL RESOURCES CO | 3,800 | $872K | 0.7% | $229.55 | $145.33 | — | COM | 723787107 |
| TXG | 10X GENOMICS INC | 21,000 | $866K | 0.7% | $41.25 * | $43.02 | +20.9% | CL A COM | 88025U109 |
| AXGN | AXOGEN INC | 173,000 | $865K | 0.7% | $5.00 * | $7.48 | -7.4% | COM | 05463X106 |
| — | KARYOPHARM THERAPEUTICS INC | 571,832 | $766K | 0.7% | $1.34 | $7.66 | — | COM | 48576U106 |
| CYTK | CYTOKINETICS INC | 25,000 | $737K | 0.6% | $29.46 * | $27.06 | +23.1% | COM | 23282W605 |
| TVTX | TRAVERE THERAPEUTICS INC | 82,000 | $733K | 0.6% | $8.94 * | $17.22 | -18.1% | COM | 89422G107 |
| DCGO | DOCGO INC | 130,000 | $693K | 0.6% | $5.33 * | $7.76 | +4.7% | COM | 256086109 |
| APLS | APELLIS PHARMACEUTICALS INC | 18,000 | $685K | 0.6% | $38.04 * | $39.43 | +11.4% | COM | 03753U106 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 38,000 | $634K | 0.5% | $16.68 * | $38.07 | -49.0% | COM | 74366E102 |
| — | SILK ROAD MEDICAL INC | 41,294 | $619K | 0.5% | $14.99 | $25.86 | — | COM | 82710M100 |
| PGNY | PROGYNY INC | 18,000 | $612K | 0.5% | $34.02 * | $35.39 | +6.7% | COM | 74340E103 |
| — | KINIKSA PHARMACEUTICALS LTD | 30,000 | $521K | 0.4% | $17.37 | $13.10 | — | COM | G5269C101 |
| KALV | KALVISTA PHARMACEUTICALS INC | 40,000 | $385K | 0.3% | $9.63 * | $18.69 | -45.3% | COM | 483497103 |
| HALO | HALOZYME THERAPEUTICS INC | 10,000 | $382K | 0.3% | $38.20 * | $51.20 | -20.0% | COM | 40637H109 |
| XENE | XENON PHARMACEUTICALS INC | 10,000 | $342K | 0.3% | $34.16 * | $30.24 | +23.7% | COM | 98420N105 |
| FOLD | AMICUS THERAPEUTICS INC | 28,000 | $340K | 0.3% | $12.16 * | $14.56 | -11.4% | COM | 03152W109 |
| STOK | STOKE THERAPEUTICS INC | 85,000 | $335K | 0.3% | $3.94 * | $13.12 | -49.9% | COM | 86150R107 |
| SRPT | SAREPTA THERAPEUTICS INC | 2,500 | $303K | 0.3% | $121.22 * | $100.79 | +12.1% | COM | 803607100 |
| ARVN | ARVINAS INC | 15,000 | $295K | 0.3% | $19.64 * | $16.46 | +49.0% | COM | 04335A105 |
| XNCR | XENCOR INC | 12,300 | $248K | 0.2% | $20.15 * | $15.78 | +44.1% | COM | 98401F105 |
| — | 2SEVENTY BIO INC | 59,833 | $235K | 0.2% | $3.92 | $19.43 | — | COM | 901384107 |
| CGEM | CULLINAN ONCOLOGY INC | 25,114 | $227K | 0.2% | $9.05 * | $40.60 | -74.3% | COM | 230031106 |
| KROS | KEROS THERAPEUTICS INC | 7,000 | $223K | 0.2% | $31.88 * | $46.71 | -20.1% | COM | 492327101 |
| GOSS | GOSSAMER BIO INC | 209,088 | $174K | 0.1% | $0.83 * | $5.35 | -78.5% | COM | 38341P102 |
| — | G1 THERAPEUTICS INC | 120,000 | $173K | 0.1% | $1.44 | $11.98 | — | COM | 3621LQ109 |
| IFRX | INFLARX NV | 50,000 | $149K | 0.1% | $2.98 * | $3.70 | +2.8% | COM | N44821101 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 20,000 | $142K | 0.1% | $7.08 | $6.02 | +19.4% | COM | 09058V103 |
| — | NEKTAR THERAPEUTICS | 28,000 | $16,677 | 0.0% | $0.60 | $15.38 | — | COM | 640268108 |
| — | YIELD10 BIOSCIENCE INC | 18,750 | $6,126 | 0.0% | $0.33 | $6.02 | — | COM | 98585K102 |